Berg, J. S., Foreman, A. K. M., O'Daniel, J. M., Booker, J. K., Boshe, L., Carey, T., . . . Evans, J. P. (2016). A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing. Genet Med.
Chicago Stili AlıntıBerg, Jonathan S., et al. "A Semiquantitative Metric for Evaluating Clinical Actionability of Incidental or Secondary Findings From Genome-scale Sequencing." Genet Med 2016.
MLA AlıntıBerg, Jonathan S., et al. "A Semiquantitative Metric for Evaluating Clinical Actionability of Incidental or Secondary Findings From Genome-scale Sequencing." Genet Med 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..